Advertisement

Adenomyose

  • Frank Nawroth
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Die Adenomyose ist nach heutigem Kenntnisstand offensichtlich für viele der klinischen Symptome verantwortlich, die ursprünglich der Endometriose zugesprochen wurden. Das Kapitel stellt die aktuellen Aspekte der Diagnostik sowie den Kenntnisstand zu unterschiedlichen therapeutischen Optionen der Adenomyose dar. Eine ursächliche Therapie vor allem bei bestehendem Kinderwunsch ist insbesondere bei der diffusen Form nicht möglich. Es bestehen noch offene Fragen zur Effektivität und klinischen Relevanz einzelner Verfahren.

Literatur

  1. Abou-Setta AM, Houston B, Al-Inany HG, Farquhar C (2013) Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev (1):CD005072Google Scholar
  2. Andres MP, Borrelli GM, Ribeiro J, Baracat EC, Abrão MS, Kho RM (2018) Transvaginal ultrasound for the diagnosis of adenomyosis: systematic review and meta-analysis. J Minim Invasive Gynecol 25:257–264Google Scholar
  3. Badawy AM, Elnashar AM, Mosbah AA (2012) Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand 91:489–495CrossRefPubMedGoogle Scholar
  4. Bazot M, Cortez A, Darai E, Rouger J, Chopier J, Antoine JM, Uzan S (2001) Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 16:2427–2433CrossRefPubMedGoogle Scholar
  5. Bazot M, Daraï E, Rouger J, Detchev R, Cortez A, Uzan S (2002) Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation. Ultrasound Obstet Gynecol 20:605–611CrossRefPubMedGoogle Scholar
  6. Bragheto AM, Caserta N, Bahamondes L, Petta CA (2007) Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 76:195–199CrossRefPubMedGoogle Scholar
  7. Bratby MJ, Walker WJ (2009) Uterine artery embolisation for symptomatic adenomyosis -mid-term results. Eur J Radiol 70:128–132CrossRefPubMedGoogle Scholar
  8. Brown J, Pan A, Hart RJ (2010) Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev (8):CD008475Google Scholar
  9. Brown J, Kives S, Akhtar M (2012) Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev (3):CD002122Google Scholar
  10. Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A (2017) Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev (1):CD004753Google Scholar
  11. Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS (2010) Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 89:1374–1384CrossRefPubMedGoogle Scholar
  12. Cheung VY (2017) Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography 36:95–102CrossRefPubMedGoogle Scholar
  13. Cho S, Nam A, Kim H, Chay D, Park K, Cho DJ, Park Y, Lee B (2008) Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol 198:373.e1–373.e7CrossRefGoogle Scholar
  14. Cirpan T, Yeniel O, Ulukus M, Ozbal A, Gundem G, Ozsener S, Mete Itil I, Zekioglu O (2008) Clinical symptoms and histopathological findings in subjects with adenomyosis uteri. Clin Exp Obstet Gynecol 35:48–53PubMedGoogle Scholar
  15. Dartmouth K (2014) A systematic review with meta-analysis: the common sonographic characteristics of adenomyosis. Ultrasound 22:148–157CrossRefPubMedPubMedCentralGoogle Scholar
  16. Davis L, Kennedy SS, Moore J, Prentice A (2007) Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev (18):CD001019Google Scholar
  17. Di Spiezio Sardo A, Calagna G, Santangelo F, Zizolfi B, Tanos V, Perino A, De Wilde RL (2017) The role of hysteroscopy in the diagnosis and treatment of adenomyosis. Biomed Res Int 2017, Art. 2518396.Google Scholar
  18. Dueholm M (2006) Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynaecol 20:569–582CrossRefPubMedGoogle Scholar
  19. Dueholm M (2017) Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand 96:715–726CrossRefPubMedGoogle Scholar
  20. Dueholm M, Lundorf E (2007) Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 19:505–512CrossRefPubMedGoogle Scholar
  21. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W, European Society of Human Reproduction and Embryology (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400–412CrossRefPubMedGoogle Scholar
  22. Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I (2008) Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online 17:244–248CrossRefPubMedGoogle Scholar
  23. Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N (2009) Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 91:675–681CrossRefPubMedGoogle Scholar
  24. Jeng CJ, Huang SH, Shen J, Chou CS, Tzeng CR (2007) Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis. Hum Reprod 22:2016–2019CrossRefPubMedGoogle Scholar
  25. Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL (2007a) Primary dysmenorrhea and risk of preterm delivery. Am J Perinatol 24:11–16CrossRefPubMedGoogle Scholar
  26. Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL (2007b) Adenomyosis and risk of preterm delivery. BJOG 114:165–169CrossRefPubMedGoogle Scholar
  27. Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, Cho JH, Cha SH (2007) Long-term results of uterine artery embolization for symptomatic adenomyosis. Am J Roentgenol 188:176–181CrossRefGoogle Scholar
  28. Kissler S, Zangos S, Wiegratz I, Kohl J, Rody A, Gaetje R, Doebert N, Wildt L, Kunz G, Leyendecker G, Kaufmann M (2007) Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci 1101:38–48CrossRefPubMedGoogle Scholar
  29. Kissler S, Zangos S, Kohl J, Wiegratz I, Rody A, Gätje R, Vogl TJ, Kunz G, Leyendecker G, Kaufmann M (2008) Duration of dysmenorrhea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol 137:204–209CrossRefPubMedGoogle Scholar
  30. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G (2005) Adenomyosis in endometriosis – prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 20:2309–2316CrossRefPubMedGoogle Scholar
  31. Kunz G, Herbertz M, Beil D, Huppert P, Leyendecker G (2007) Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online 15:681–685CrossRefPubMedGoogle Scholar
  32. Leyendecker G, Herbertz M, Kunz G, Mall G (2002) Endometriosis results from the dislocation of basal endometrium. Hum Reprod 17:2725–2736CrossRefPubMedGoogle Scholar
  33. Mochimaru A, Aoki S, Oba MS, Kurasawa K, Takahashi T, Hirahara F (2015) Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement. J Obstet Gynaecol Res 41:529–533CrossRefPubMedGoogle Scholar
  34. Molinas CR, Campo R (2006) Office hysteroscopy and adenomyosis. Best Pract Res Clin Obstet Gynaecol 20:557–567CrossRefPubMedGoogle Scholar
  35. Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O (2011) Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online 22:94–99CrossRefPubMedGoogle Scholar
  36. Osuga Y, Fujimoto-Okabe H, Hagino A (2017) Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril 108:673–678CrossRefPubMedGoogle Scholar
  37. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG (1997) Risk factors for adenomyosis. Hum Reprod 12:1275–1279Google Scholar
  38. Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P, GISE (2009) Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol 143:103–106CrossRefPubMedGoogle Scholar
  39. Parker JD, Leondires M, Sinaii N, Premkumar A, Nieman LK, Stratton P (2006) Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril 86:711–715CrossRefPubMedGoogle Scholar
  40. Peric H, Fraser IS (2006) The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20:547–555CrossRefPubMedGoogle Scholar
  41. Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S (2016) Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol 32:696–700CrossRefPubMedGoogle Scholar
  42. Popovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA (2011) Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol 22:901–909CrossRefPubMedGoogle Scholar
  43. Rabinovici J, Inbar Y, Eylon SC, Schiff E, Hananel A, Freundlich D (2006) Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 21:1255–1259CrossRefPubMedGoogle Scholar
  44. Sammour A, Pirwany I, Usubutun A, Arseneau J, Tulandi T (2002) Correlations between extent and spread of adenomyosis and clinical symptoms. Gynecol Obstet Invest 54:213–216CrossRefPubMedGoogle Scholar
  45. Selak V, Farquhar C, Prentice A, Singla A (2007) Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev (4):CD000068Google Scholar
  46. Sheng J, Zhang WY, Zhang JP, Lu D (2009) The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 79:189–193CrossRefPubMedGoogle Scholar
  47. Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010a) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151:193–198CrossRefPubMedGoogle Scholar
  48. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C (2010b) Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 25:633–641CrossRefPubMedGoogle Scholar
  49. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A, Reynolds P, Cress R, Anton-Culver H, West D, Ross RK, Bernstein L (2008) Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 90:415–424CrossRefPubMedGoogle Scholar
  50. Tocci A, Greco E, Ubaldi FM (2008) Adenomyosis and ‚endometrial-subendometrial myometrium unit disruption disease‘ are two different entities. Reprod Biomed Online 17:281–291CrossRefPubMedGoogle Scholar
  51. Vercellini P, Vigano P, Somigliana E, Fedele L (2013) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10:261–275CrossRefPubMedGoogle Scholar
  52. Wada S, Kudo M, Minakami H (2006) Spontaneous uterine rupture of a twin pregnancy after a laparoscopic adenomyomectomy: a case report. J Minim Invasiv Gynecol 13:166–168CrossRefGoogle Scholar
  53. Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM (2009) Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women’s Health Across the Nation (SWAN). Fertil Steril 91:201–206CrossRefPubMedGoogle Scholar
  54. Yeniel O, Cirpan T, Ulukus M, Ozbal A, Gundem G, Ozsener S, Zekioglu O, Yilmaz H (2007) Adenomyosis: prevalence, risk factors, symptoms and clinical findings. Clin Exp Obstet Gynecol 34:163–167PubMedGoogle Scholar
  55. Younes G, Tulandi T (2018) Conservative surgery for adenomyosis and results: a systematic review. J Minim Invasive Gynecol 25:265–276Google Scholar
  56. Zacharia TT, O’Neill MJ (2006) Prevalence and distribution of adnexal findings suggesting endometriosis in patients with MR diagnosis of adenomyosis. Br J Radiol 79:303–307CrossRefPubMedGoogle Scholar
  57. Zaloudek C, Norris HJ (1987) Mesenchymal tumors of the uterus. In: Kurmann RJ (Hrsg) Blaunstein’s pathology of the female genital tract, 3. Aufl. Springer, New York, S 374Google Scholar
  58. Zhang L, Rao F, Setzen R (2017) High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand 96:707–714CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Facharzt-Zentrum für Kinderwunsch, Pränatale Medizin, Endokrinologie und Osteologieamedes MVZ HamburgHamburgDeutschland

Personalised recommendations